On the Horizon is designed to showcase a recent finding in the scientific literature that is likely to have a significant impact on our understanding of skin disease pathogenesis and ultimately contribute to more effective disease management. While treatment is an obvious focal point of the section, other elements of improved disease management might include prevention, counseling, and public policy. The section is intended to have a concise, consistent structure. It begins with an abstract reprinted from the scientific literature that represents the focus of the article. This is followed by a short commentary of approximately 500 words and a few relevant references. If crucial to the message, 1 or 2 figures or tables might be included. The content should be focused and contained to a single page of the ARCHIVES.
To achieve our goal of making On the Horizon a monthly feature of the ARCHIVES, we need your help. We know that excitement about advances in dermatology is shared by many dermatologists in and out of academics, as well as fellows, residents, and students. We invite all kindred spirits to submit material to On the Horizon. This is an excellent opportunity for residency program directors and other faculty mentors to get their trainees involved in writing about, not just reading about, scientific advances relevant to dermatology. Submissions may go directly to Gary S. Wood, MD, the section editor, or through one of the assistant section editors.
On the Horizon. Arch Dermatol. 2007;143(3):402. doi:10.1001/archderm.143.3.402